Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引：35

作者：

Bresalier, Robert S. ^{[1
]}

Kopetz, Scott ^{[2
]}

Brenner, Dean E. ^{[3
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA

[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA

来源：

DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 03期

关键词：

Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;

D O I：

10.1007/s10620-015-3575-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.

引用

页码：664 / 671

页数：8

共 66 条

[11] A circulating ligand for galectin-3 glycoprotein elevated in individual is a haptoglobin-related with colon cancer
Bresalier, RS
Byrd, JC
Tessler, D
Lebel, J
Koomen, J
Hawke, D
Half, E
Liu, KF
Mazurek, N
[J]. GASTROENTEROLOGY, 2004, 127 (03) : 741 - 748
[12] Vascular endothelial growth factor (VEGF) -: a valuable serum tumour marker in patients with colorectal cancer?
Broll, R
Erdmann, H
Duchrow, M
Oeverman, E
Schwandner, O
Markert, U
Bruch, HP
Windhövel, U
[J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (01): : 37 - 42
[13] Chen Y, 2007, INT J ONCOL, V30, P1137
[14] Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Church, Timothy Robert
Wandell, Michael
Lofton-Day, Catherine
Mongin, Steven J.
Burger, Matthias
Payne, Shannon R.
Castanos-Velez, Esmeralda
Blumenstein, Brent A.
Roesch, Thomas
Osborn, Neal
Snover, Dale
Day, Robert W.
Ransohoff, David F.
[J]. GUT, 2014, 63 (02) : 317 - 325
[15] Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, Marina
Raposo, Graca
Thery, Clotilde
[J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30, 2014, 30 : 255 - 289
[16] Loss of imprinting of insulin growth factor II gene: A potential heritable biomarker for colon neoplasia predisposition
Cruz-Correa, M
Cui, HM
Giardiello, FM
Powe, NR
Hylind, L
Robinson, A
Hutcheon, DF
Kafonek, DR
Brandenburg, S
Wu, YQ
He, XB
Feinberg, AP
[J]. GASTROENTEROLOGY, 2004, 126 (04) : 964 - 970
[17] Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk
Cui, HM
Cruz-Correa, M
Giardiello, FM
Hutcheon, DF
Kafonek, DR
Brandenburg, S
Wu, YQ
He, XB
Powe, NR
Feinberg, AP
[J]. SCIENCE, 2003, 299 (5613) : 1753 - 1755
[18] Cui HM, 2002, CANCER RES, V62, P6442
[19] Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F
Li, M
Dressman, D
He, YP
Shen, D
Szabo, S
Diaz, LA
Goodman, SN
David, KA
Juhl, H
Kinzler, KW
Vogelstein, B
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (45) : 16368 - 16373
[20] A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases
Feldman, AL
Alexander, HR
Bartlett, DL
Kranda, KC
Miller, MS
Costouros, NG
Choyke, PL
Libutti, SK
[J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (09) : 741 - 745

← 1 2 3 4 5 6 7 →